Non-specific histamine release activity of busereline, LH-releasing hormone
- 1 October 1988
- Vol. 43 (7) , 540-541
- https://doi.org/10.1111/j.1398-9995.1988.tb01634.x
Abstract
Busereline acetate is an LH-RH agonist that was found to induce local reactions at the injection site or generalized minor skin reactions in som patients. Since these reactions may represent the first reaction of systemic anaphylaxis, we tested the non-specific histamine releasing activity of this drug by intradermal skin tests. It was found that all subjects tested had a positive wheal and flare reaction, the flare being significantly decreased by terfenadine. Benzyl alcohol, the preservative used in commerical preparation of busereline acetate, did not elicit a positive wheal and flare reaction in two patients who had experienced a clinically noticeable rection. It is concluded that busereline is likely to be a non-specific histamine releasing compound.Keywords
This publication has 4 references indexed in Scilit:
- Decreased skin response to intradermal histamine in cancer patientsJournal of Allergy and Clinical Immunology, 1986
- Buserelin as primary therapy in advanced prostatic carcinomaCancer, 1985
- Antibody production against an agonist analogue of luteinizing hormone-releasing hormone: evaluation of immunochemical and physiological consequencesActa Endocrinologica, 1983
- Allergic paraben and benzyl alcohol hypersensitivity relationship of the “delayed” and “immediate” varietiesContact Dermatitis, 1975